' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Minimally Invasive Retroperitoneal Lymphadenectomy.
Lusuardi, L; Kunit, T; Janetschek, G
J Endourol. 2018; 32(S1):S97-S104
Originalarbeiten (Zeitschrift)


Janetschek Günter
Kunit Thomas
Lusuardi Lukas


The feasibility of laparoscopic retroperitoneal lymphadenectomy (RLA) for testicular cancer was shown >25 years ago. Initially the indication was clinical stage I (CS I) nonseminomatous germ cell tumor (NSGCT). Compared with that of open surgery, the morbidity was much decreased. However, in Europe, surgery for CS I is now replaced by chemotherapy. A relatively new indication is laparoscopic retroperitonal lymphadenectomy for small unilateral residual tumor after chemotherapy. The technique of unilateral lymphadenectomy for both indications is described in detail and with a video. The most recent development is bilateral laparoscopic RLA for residual tumors larger than 5 cm.

Find related publications in this database (Keywords)

retroperitoneal lymphadenectomy
minimally invasive surgery
laparoscopic surgery
retroperitoneal lymph node dissection